Abbott today announced the initiation of MOBILITY, a clinical trial studying the safety and efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in patients with iliac artery disease.
Clinical Trials
Clinical Trial Findings Show Significant Benefits With CVRx® Rheos® System
CVRx announced that longer-term data from early Rheos clinical studies show significant reductions in hypertension and improvements in heart structure and function.
Trial Shows Important Clinical Benefit Of MitraClip® Therapy In High Risk Patients
Percutaneous mitral valve repair using the MitraClip® system in high-risk surgical patients with improves patient clinical status according to data from the registry arm of the EVEREST II study.
Thrombus Aspiration With Medtronic’s Export Catheter May Improve Outcomes For Heart Attack Patients
Removing thrombus from coronary arteries with the Export Aspiration Catheter from Medtronic, Inc., before implanting a stent in patients suffering a specific kind of heart attack, “results in excellent clinical outcomes,” at one year, according to new data released today at the American College of Cardiology meeting.
Medtronic’s Endeavor Stent Shows Consistent And Sustained Safety And Effectiveness Benefits At Two Years
New data released at the 2009 American College of Cardiology meeting demonstrated exceptional long-term safety and effectiveness results for the Endeavor drug-eluting coronary stent from Medtronic, Inc.
Drug-Coated Stents Lower Risk Of Heart Attack And Death
Heart disease patients 65 and older who receive stents coated with medicine are more likely to survive and less likely to suffer a heart attack than people fitted with bare metal stents, according to a new study.
MEDIHONEY™ Dressings Shown to Improve Outcomes of Non-Healing Venous Leg Ulcers
Derma Sciences, Inc., a provider of advanced wound care products, announced today that its MEDIHONEY Dressings were the focus of a case series on eleven non-healing venous leg ulcers.
Abbott Advances its Revolutionary Fully Bioabsorbable Drug Eluting Stent with Initiation of Next Phase of Clinical Trial
Abbott today announced the initiation of the next phase of the ABSORB clinical trial to evaluate the safety and performance of the company’s fully bioabsorbable drug eluting coronary stent.
New Study Reconfirms Long-Term Strength of Biodesign Hernia Graft
A five-year study confirms the long-term strength and durability of the Biodesign™ Hernia Graft, Cook Medical, a world leader in advanced tissue repair, announced today.
Cordis Corporation Announces Head-to-Head Randomised Clinical Trial Comparing the NEVO Sirolimus-Eluting Coronary Stent to the XIENCE Stent
Cordis Corporation, a worldwide leader in the field of interventional cardiology, announced plans today to launch a global, head-to-head, randomized clinical trial called NEVO II which will compare the NEVO™ Sirolimus-eluting Coronary Stent to the XIENCE V™ Everolimus-eluting Coronary Stent.
BioSyntech to Conduct Substantial Interim Analysis on Half of Enrolled Patients from BST-CarGel® Pivotal Trial
BioSyntech, Inc. today announced that it will conduct an interim analysis of the available clinical data from 40 subjects who have completed their 12 month follow-up in the 80 subject trial for its cartilage repair device, BST-CarGel®.
Angiotech announces Positive Results from Bio-Seal™ Clinical Study
Angiotech Pharmaceuticals, Inc. today announced positive clinical study results for its Bio-Seal™ Lung Biopsy Tract Plug System at the
Society of Interventional Radiologists Annual Scientific Meeting in San Diego, CA.